2024-04-01 2025-03-31 false Capium Accounts Production 1.1 10418213 2024-04-01 2025-03-31 10418213 bus:AbridgedAccounts 2024-04-01 2025-03-31 10418213 bus:Micro-entities 2024-04-01 2025-03-31 10418213 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10418213 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10418213 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10418213 2024-04-01 2025-03-31 10418213 2025-03-31 10418213 bus:RegisteredOffice 2024-04-01 2025-03-31 10418213 core:WithinOneYear 2025-03-31 10418213 core:AfterOneYear 2025-03-31 10418213 1 2024-04-01 2025-03-31 10418213 bus:Director1 2024-04-01 2025-03-31 10418213 bus:Director1 2025-03-31 10418213 bus:Director1 2023-04-01 2024-03-31 10418213 bus:Director2 2024-04-01 2025-03-31 10418213 bus:Director2 2025-03-31 10418213 bus:Director2 2023-04-01 2024-03-31 10418213 2023-04-01 10418213 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 10418213 2023-04-01 2024-03-31 10418213 2024-03-31 10418213 core:WithinOneYear 2024-03-31 10418213 core:AfterOneYear 2024-03-31 10418213 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 10418213 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 10418213 bus:OrdinaryShareClass1 2025-03-31 10418213 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 10418213 bus:OrdinaryShareClass1 2024-03-31 10418213 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 10418213 bus:OrdinaryShareClass2 2025-03-31 10418213 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 10418213 bus:OrdinaryShareClass2 2024-03-31 10418213 core:ComputerEquipment 2024-04-01 2025-03-31 10418213 core:ComputerEquipment 2025-03-31 10418213 core:ComputerEquipment 2024-03-31 10418213 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 10418213 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 10418213 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 10418213 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 10418213 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 10418213 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 10418213 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 10418213 core:Non-currentFinancialInstruments 2025-03-31 10418213 core:Non-currentFinancialInstruments 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10418213
England and Wales

 

 

 

PMK MED CARE LTD



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025
  2025   2024
    £ £   £ £
Fixed assets   30,857      27,801 
Current assets 14,497      38,191   
Creditors: amount falling due within one year (36,154)     (52,016)  
Net current assets   (21,657)     (13,825)
Total assets less current liabilities   9,200      13,976 
Net assets   9,200      13,976 
 

         
Capital and reserves   9,200      13,976 
 
NOTES TO THE ACCOUNTS

General Information
PMK MED CARE LTD is a private company, limited by shares, registered in England and Wales, registration number 10418213, registration address Office Gold Building 7, Floor 5, 566 Chiswick High Road, Chiswick Business Park, London, W4 5YA.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 18 Reducing Balance
2.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 April 2024 1,870    1,870 
Additions  
Disposals  
At 31 March 2025 1,870    1,870 
Depreciation
At 01 April 2024 1,069    1,069 
Charge for year 144    144 
On disposals  
At 31 March 2025 1,213    1,213 
Net book values
Closing balance as at 31 March 2025 657    657 
Opening balance as at 01 April 2024 801    801 


3.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).

4.

Ultimate Control

Dr. Kiran Kumar Mummaneni and Dr. Pratima Chowdary Mamillapalli are the Directors and Dr. Kiran Kumar Mummaneni is the significant share holder of the company.

For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the board of directors on 25 December 2025 and were signed on its behalf by:


--------------------------------
Dr. Kiran Kumar Mummaneni
Director
1